Safety of Stem Cell – Derived Therapies: Trends and Future Technologies

Event Date: October 7th - 8th 2019


Registration: OPEN (deadline 27 September 2019)
Abstract submission: OPEN (deadline 06 September 2019)

This important meeting, held at the John McIntyre Centre in Edinburgh, is brought to you by the UK Regenerative Medicine Platform (UKRMP) and the British Pharmacological Society.

Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.

Across two days, we will discuss how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We will also look at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.

This meeting will be of particular interest to pharmacologists, those working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, will also be joining our panel discussions.

Hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan, David Hay, Richard Adair, Sarah Waters and our key note speaker, Jane Lebkowski.

CPD points from the Royal College of Physicians and Royal Society of Biology are available at this meeting. You will be emailed a certificate of attendance with CPD points after the meeting.

Submit an abstract

Poster presentations are available at this meeting. Please submit an abstract for the meeting before the deadline, 06 September 2019.

Please refer to our abstract guidelines for authors for more information on submitting an abstract for the meeting.

If you have any questions about the abstract submission process please email

More information